# FDA Inspection 1327022 - Octapharma Plasma Inc - July 10, 2026

Source: https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/e00e4431-7140-48fe-841b-189d5fcd5fe4
Source feed: FDA_Inspections

> FDA Inspection 1327022 for Octapharma Plasma Inc on July 10, 2026. Classification: N/A.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1327022
- Company Name: Octapharma Plasma Inc
- Inspection Date: 2026-07-10
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: New Jersey District Office

## Related Documents

- [FDA Inspection 1214337 - 2023-07-21](https://www.keypedia.com/records/fda_inspections/octapharma-plasma-inc/d1bdbecd-641b-4c40-9cc0-5f8b9d5950fb)

Company: https://www.keypedia.com/companies/octapharma-plasma-inc/91eef912-b5fc-4a98-ac5f-b928e91c58b8

Office: https://www.keypedia.com/offices/new-jersey-district-office/6ff5e2e9-5cff-44c7-af24-5a55329a8248